YSWY NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Yesway, Inc. Class A Common Stock · Consumer Defensive · Grocery Stores

Open interactive chart View report data Download investor PDF
Latest close 19.69 USD
-5.7% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is - below the Trend Line and sits at 7.6% of its 52-week range. The latest completed week returned -5.7%, after a -6.3% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 56/100. Near-term considerations: volume confirmation is below normal; earnings are due in 15d.

Setup score 23 out of 100
Latest Close 19.69 USD 24 Jul 2026
1W Return -5.7% latest completed week
4W Return -6.3% short-term follow-through
12W Return -27.1% quarterly tape
Trend Breadth 0.0% 0 of 14 weeks active
Volume Ratio 0.5x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
  • Next-week expectancy is negative at 42.90% based on similar historical setup states.
What to watch next
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -5.7% Latest completed week; four-week move -6.3%. Indicator stack 0/50 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 42.90% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 56/100 30 relevant articles in the latest sentiment read. Event risk 15d Next report is scheduled for 14 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is - below the Trend Line and sits at 7.6% of its 52-week range. The latest completed week returned -5.7%, after a -6.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1912-week average 0.20

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.19Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -6.3% over four weeks, -27.1% over 12 weeks, and - over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-5.7%
4W-6.3%
12W-27.1%
26W-
52W-
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.00Latest activity-pressure read.
Pressure change-Four-week change in activity pressure.
Leadership-Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength23/100Blend of value, momentum, and quality. Underlying universe rank 78; rank 1 is best.
Value22/100Relative valuation strength. Underlying universe rank 79; rank 1 is best.
Quality71/100Profitability and accounting quality. Underlying universe rank 30; rank 1 is best.
Momentum36/100Medium-term price momentum. Underlying universe rank 65; rank 1 is best.
Growth12/100Revenue and earnings growth. Underlying universe rank 89; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework18/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
110.1x
Price divided by trailing earnings.
Price / sales
0.5x
Market value relative to trailing revenue.
EV / EBITDA
16.6x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
9.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
21.7%
Gross profit retained from each unit of revenue.
Operating margin
3.3%
Operating profit retained from revenue.
Free-cash-flow margin
9.3%
Free cash flow generated from revenue.
Return on invested capital
8.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
5.8%
Latest one-year revenue growth.
EPS growth
-51.6%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
21.4%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.8%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
6.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment56/100

Weighted news tone is neutral across 30 relevant articles.

9 positive · 21 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings15dNext report is scheduled for 14 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-32.3%Distance below the 52-week high.
13-week volatility8.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher5 of 138 weeks finished lower.
Best week+24.1%Week of 1 May.
Worst week-12.0%Week of 19 Jun.
Latest week-5.7%Week of 24 Jul.

Shape of recent returns

Strong gains2
Modest gains3
Flat weeks0
Modest losses4
Sharp losses4
Recent vol8.4%13-week weekly-return volatility.
Base vol8.4%52-week weekly-return volatility.
Up/down split5/8Count of positive and negative weeks in the 52-week window.
Average skew6.9% / -5.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape24/100

Trend, activity pressure, participation, and risk combine to a 24/100 tape read.

 Indicator analysis8/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.19; 2 reversal markers Next-Week ExpectancyNegative 42.90%

Next-week expectancy is negative with a 42.90% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors37/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 61; Small Cap Core rank 79 SVQF18/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 593.0 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment56/100

Weighted news tone is neutral across 30 relevant articles.

symbol__ Stock Quote Price and Forecast Insiders50/100

No recent insider transaction evidence is stored.

 Earnings15d

Next report is scheduled for 14 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202619.69 USD-5.7%-22.49 USD0.00-1.2MOff
17 Jul 202620.89 USD2.5%-22.70 USD0.00-1.5MOff
10 Jul 202620.38 USD-1.9%-22.86 USD0.00-1.3MOff
3 Jul 202620.77 USD-1.1%-23.08 USD0.00-2.3MOff
26 Jun 202621.01 USD2.7%-23.31 USD0.00-5.8MOff
19 Jun 202620.45 USD-12.0%-23.57 USD0.00-3.0MOff
12 Jun 202623.24 USD4.8%-23.96 USD0.00-2.6MOff
5 Jun 202622.18 USD-1.4%-24.06 USD0.00-2.3MOff
29 May 202622.50 USD-3.7%-24.37 USD0.00-1.6MOff
22 May 202623.37 USD-9.6%-24.75 USD0.00-1.6MOff
15 May 202625.84 USD0.3%-25.09 USD0.00-1.5MOff
8 May 202625.77 USD-4.6%-24.84 USD--2.3MOff
1 May 202627.00 USD24.1%-24.38 USD--3.4MOff
24 Apr 202621.75 USD--21.75 USD--10.6MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.